The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.
The FDA’s influence in the prescription drug market remains the largest obstacle to deregulation.
Right-to-try will never reach its potential without deregulation.
Recent events indicate an urgent need for researchers and policymakers to relearn the basics.
FDA launches anti-vaping campaign.
The only reliable remedy to mitigate shortages of any product is to allow competition in the market.
Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.
The real threat to free markets lies in the regulatory state.
Bryan W. Van Norden argues that the ignorant do not have a right to an audience.
One hidden cost of inflation is that it makes an increasingly large share of cash holdings and transactions subject to government surveillance.